Telbivudine associated mitochondrial myopathy

Liver Int. 2018 Jun;38(6):1139. doi: 10.1111/liv.13742. Epub 2018 Apr 20.

Authors

Su-Shen Lim¹, Hsien-Tzung Liao^{1

2

3}, Chang-Youh Tsai^{1

3}

Affiliations

¹ Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
² Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
³ School of Medicine, College of Medicine, National Yang-Ming University, Taipei, Taiwan.

PMID: 29570939
DOI: 10.1111/liv.13742

No abstract available

Publication types

Case Reports

MeSH terms

Antiviral Agents / adverse effects*
Hepatitis B, Chronic / drug therapy*
Humans
Male
Middle Aged
Mitochondrial Myopathies / chemically induced*
Mitochondrial Myopathies / pathology*
Telbivudine / adverse effects*

Substances

Antiviral Agents
Telbivudine